Catalyst Wire Dossier Catalyst Wire Dossier

TK-based suicide gene therapy

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TK-based suicide gene therapy, covering 2013-01-16 to 2013-01-16. Get the full timeline:

Most recent: Clinical Trial Update: TK-based Suicide Gene Therapy for Hepatocellular Carcinoma [Phase 1]

See pricing